Cequent Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate i... (/b In October 2009 Cequent announced ...)

Cequent Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate in Oncology

Date:11/12/2009

/b>

In October 2009, Cequent announced that it had initiated a Series B round of financing, seeking to raise $15 million to take the company through Phase II clinical trials with its lead drug candidate. This week, it closed on $3.35 million in first-tranche equity financing. Participating investors included Ampersand Ventures, Gold Hill Capital, Novartis Option Fund, Pappas Ventures, and Yasuda Enterprise Development, all of whom participated in the company's Series A funding in 2007. A second tranche from this group is expected to yield $3.2 million in 2010, subject to successful advancement of Cequent's tkRNAi technology into human studies.

SOURCE Cequent Pharmaceuticals

SOURCE Cequent Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Alvarado Hospital Files Countersuit Against Blue Shield
2. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
3. Pharsight Files Application for Nasdaq Capital Market Listing
4. Gentiva(R) Health Services Files Universal Shelf Registration Statement
5. Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx
6. CIGNA Behavioral Health Offers Members Online Provider Profiles
7. American Media Operations, Inc. Files Form 10-Q For First Quarter 2007
8. RxElite Files Registration Statement with Securities and Exchange Commission
9. Dynamic Files Articles of Merger; Notifies Nasdaq of Merger with GeoPharma
10. Mach One Corporation Files its Form SB-2 with the SEC
11. CryoCath files patent infringement lawsuit

Post Your Comments:

(Date:3/17/2010)... March 17 Feeding America President and CEO, Vicki Escarra , today issued the following statement regarding the Reauthorization of ... ... ... ... "On behalf of ...

(Date:3/17/2010)... , March 17 You take your child to the dentist for ... at your own checkup that your dentist recommends braces. Upon hearing the news, you most ... long they have to be worn. If you,re an adult, you may be surprised to ... ... ...

(Date:3/17/2010)... ... , ... ... ... (D-VA.), Dale Kildee (D-MI) and Jim Oberstar (D-MI), all declared support for the Senate health care bill, despite its provisions that would ...

(Date:3/17/2010)... pregnant women, researchers say , , WEDNESDAY, March 17 (HealthDay ... may suffer more severe brain damage than children exposed ... , "We know that alcohol exposure is toxic to ... cognitive and behavioral problems," research team leader Elizabeth Sowell, ... a news release. "In this study, we show that ...

(Date:3/17/2010)... , ... Abington, PA (Vocus) March 17, 2010 -- ... was the first in Pennsylvania to treat leg pain and numbness ... (ISS) from VertiFlex® Inc., , ,The procedure performed by Lee ... effectiveness of this new device in the treatment of leg pain ...

Breaking Medicine News(10 mins):Health News:Statement from Vicki Escarra, President and CEO, Feeding America, on the Child Nutrition Reauthorization Draft Legislative Proposal 2 Health News:Statement from Vicki Escarra, President and CEO, Feeding America, on the Child Nutrition Reauthorization Draft Legislative Proposal 3 Health News:PDA Presents the Facts on Braces 2 Health News:PDA Presents the Facts on Braces 3 Health News:PDA Presents the Facts on Braces 4 Health News:PDA Presents the Facts on Braces 5 Health News:FRCA Asks: 'What did Representatives Perriello, Kildee and Oberstar Receive in Exchange for Betraying the Pro-Life Cause?' 2 Health News:FRCA Asks: 'What did Representatives Perriello, Kildee and Oberstar Receive in Exchange for Betraying the Pro-Life Cause?' 3 Health News:Meth Exposure May Be Worse for Fetus Than Alcohol 2 Health News:Abington Surgeon First in Pennsylvania to Implant Investigative Device to Treat Leg Pain Caused by Spinal Stenosis 2 Health News:Abington Surgeon First in Pennsylvania to Implant Investigative Device to Treat Leg Pain Caused by Spinal Stenosis 3 Health News:Abington Surgeon First in Pennsylvania to Implant Investigative Device to Treat Leg Pain Caused by Spinal Stenosis 4

[1] Statement from Vicki Escarra, President and CEO, Feeding America, on the Child Nutrition Reauthorization Draft Legislative Proposal [0] PDA Presents the Facts on Braces [0] FRCA Asks: 'What did Representatives Perriello, Kildee and Oberstar Receive in Exchange for Betraying the Pro-Life Cause?'[0] Meth Exposure May Be Worse for Fetus Than Alcohol [0] Abington Surgeon First in Pennsylvania to Implant Investigative Device to Treat Leg Pain Caused by Spinal Stenosis

... services has become an increasingly important issue with the ... ,Four separate articles in the latest ... related to the implementation of the program. ... Head of Colorectal Medicine and Genetics at Royal Melbourne ...

... father passed on a rare side effect of the smallpox vaccination ... , The boy who is currently being treated at University ... 80 percent of his body. ,Eczema vaccinatum is an ... who receive the shot or their close contacts. , ...

... a ray of hope to persons suffering from aniridia - a ... 1,000 people in the UK alone, suffer from this rare ... cells that can rejuvenate tissue in the eye. ,Sufferers ... or cataracts - when they are young. , Aniridia ...

... be gold, according to the journal Proceedings of the National ... vaccines are losing their efficiency in// preventing tuberculosis, and scientists ... , The scientists led by Dr. Roland Brosch ... or bacillus Calmette Guerin vaccines used in immunization ...

... the ill effects of second-hand tobacco smoke than their white ... with asthma. ,Black children who were exposed to ... levels in their hair and blood than white children with ... metabolize or break down nicotine more slowly than white children," ...

... is the first in the state to perform a ... stimulate regeneration of the heart muscle after a// heart ... centers in the country providing this new treatment modality ... Amorcyte, a privately funded cell-therapy company studying stem cells ...

Other Medicine News:Health News:Bowel Cancer Screening Program 2 Health News:Toddler Infected With Rare Side Effect of Smallpox Vaccine 2 Health News:TB Vaccines: Ring Out the New, Bring in the Old 2 Health News:Vanderbilt Performs State's First Stem Cell Heart Regeneration Therapy 2 Health News:Vanderbilt Performs State's First Stem Cell Heart Regeneration Therapy 3

Bowel Cancer Screening Program Toddler Infected With Rare Side Effect of Smallpox Vaccine Let Blind Eyes Be Opened - Stem Cell Therapy and Aniridia TB Vaccines: Ring Out the New, Bring in the Old Black Children More Vulnerable to Tobacco Smoke Effects Vanderbilt Performs State's First Stem Cell Heart Regeneration Therapy

(Date:3/17/2010)... , March 17 Zogenix, ... that it has initiated a pivotal Phase 3 ... formulation of hydrocodone without acetaminophen. ZX002 is being ... pain in individuals who require around-the-clock opioid therapy ... most widely prescribed drug in the United ...

(Date:3/17/2010)... Executives from pharmaceutical companies and health care payer and provider organizations ... discuss mutually beneficial partnerships that, if implemented, could replace the traditional model of ... on quantifying and communicating total value. , ... ... ...

(Date:3/17/2010)... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Barclays, 2010 ... ... , , ... ... ...

[0] Zogenix Initiates Pivotal Phase 3 Clinical Trial for Novel Formulation of Oral Controlled-Release Hydrocodone [0] Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum [0] Isis Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference

... 12 Recent guidelines published by the,Clinical Resource ... use of bioimpedance technology for the early assessment ... titled "Guidelines for,the Diagnosis, Assessment and Management of ... patients and healthcare professionals that,reviewed the evidence for ...

... Md., June 12 ,Micromet, Inc. (Nasdaq: MITI ... has started treatment in a multi-center, phase 2 ... in,patients with adult acute lymphoblastic leukemia (ALL). Blinatumomab ... antigen, which is only expressed,on B cells. The ...

Other Medicine Technology:Published Guidelines Further Support Use of Bioimpedance Measurement Technology for Early Assessment of Lymphedema 2 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 2 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 3 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 4 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 5 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia 6

Published Guidelines Further Support Use of Bioimpedance Measurement Technology for Early Assessment of Lymphedema Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia

...

The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....

Medicine Products:

Hudson-Downs Burr McKenzie Enlarging Burr Adson Perforating Burr Doro Halo Retractor System

Cequent Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate i...(/b In October 2009 Cequent announced ...),Health